Xlera8

Jazz Pharmaceuticals Plc, %90 CBD ve THC ile CBD Hazırlığı İçin Patent Aldı - Tıbbi Esrar Programı Bağlantısı

GlobalData'nın şirket profiline göre Caz İlaçları, Cancer treatment biomarkers was a key innovation area identified from patents. Caz İlaçlarıŞubat 2024 itibarıyla hibe payı %47 oldu. Hibe payı, hibe sayısının toplam patent sayısına oranı esas alınarak hesaplanır.

Cbd preparation with at least 90% cbd and thc

Source: United States Patent and Trademark Office (USPTO). Credit: Jazz Pharmaceuticals Plc

A recently granted patent (Publication Number: US11865102B2) discloses a cannabidiol (CBD) preparation with a high concentration of CBD, greater than or equal to 90% (w/w) based on the total amount of cannabinoids in the preparation. The remaining cannabinoids in the preparation include tetrahydrocannabinol (THC), present as a mixture of trans-THC and cis-THC, with a specific ratio ranging from about 0.7:1.0 to about 5.0:1.0. Additionally, the CBD preparation contains not more than 1.5% (w/w) THC, with specific ranges of THC content specified in the claims.

Furthermore, the patent covers the use of this CBD preparation in pharmaceutical compositions for treating epilepsy, specifically targeting conditions such as Dravet syndrome, Lennox Gastaut syndrome, Doose syndrome, or tuberous sclerosis complex (TSC). The method involves administering a therapeutically effective amount of the CBD preparation, with specified dosage ranges from about 5 mg/kg/day to…

Orjinal Yazar Bağlantısının tamamını okumak için tıklayınız ..

Bizimle sohbet

Merhaba! Size nasıl yardım edebilirim?